Hepatitis B DNA vaccine (Guangzhou Baidi Biotechnology)

N/A

Report date: 2026/01/19 20:02:34

Base Information

Drug NameHepatitis B DNA vaccine (Guangzhou Baidi Biotechnology)
Drug Alias Name乙型肝炎DNA疫苗 - 广州拜迪生物医药（广东）double-plasmid HBV DNA vaccine
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Baiyunshan Baidi Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe 458 Hospital Of Chinese People'S Liberation ArmyGuangzhou Baiyunshan Pharmaceutical Holdings Company LtdGuangzhou Baiyunshan Baidi Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A